We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The Higher Arbitrazh Court of Russia, for the first time, considered novelty and other patentability requirements in a patent infringement case, which had been previously exclusively considered by the Patent and Trademark office
The Higher Arbitrazh Court of Russia invalidated the provision of the Administrative Regulation on Patent Term Extension (PTE) which dealt with medicines due to its limited scope compared with the broader definition in the new Federal Law on the Circulation of Medicines of April 2010
